| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |